FDA 新 appointed 委员会不顾工作人员反对，建议允许专业药房配制六种肽类药物
An U.S. Food and Drug Administration (FDA) committee made up of new appointees who consulted with or were employed by companies that were interested i...
AI 导读
TIME 报道，由新任命成员组成的美国 FDA（FDA）委员会建议允许专业药房配制六种肽类药物，这些成员曾为有意推广或配制肽类药物的公司提供咨询或受雇于这些公司，而 FDA 工作人员此前建议不采取这一举措。